| Dr Ruby C Alonzo, MD | |
|
110 Hospital Rd, Suite #211, Prince Frederick, MD 20678-4019 | |
| (410) 535-5610 | |
| (410) 535-6836 |
| Full Name | Dr Ruby C Alonzo |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 110 Hospital Rd, Prince Frederick, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386776193 | NPI | - | NPPES |
| 6906-0001 | Other | BLUE SHIELD DC | |
| 367313 | Other | MAMSI UNITED HEALTH CARE | |
| 410213-03 | Other | BLUE SHIELD OF MARYLAND | |
| 2217644 | Other | AETNA US HEALTHCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D0029702 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ruby C Alonzo, MD 110 Hospital Rd, Suite #211, Prince Frederick, MD 20678-4019 Ph: (410) 535-5610 | Dr Ruby C Alonzo, MD 110 Hospital Rd, Suite #211, Prince Frederick, MD 20678-4019 Ph: (410) 535-5610 |
News Archive
AbbeyMoor Medical Inc., a developer and manufacturer of medical devices for the management and treatment of prostatic obstruction, announced today that it has received PMA approval from the US Food and Drug Administration (FDA) for design changes to their flagship product, The Spanner Prostatic Stent.
Esophageal cancer patients with positive lymph nodes benefit from neoadjuvant therapy prior to surgical resection, but limitations in current clinical staging techniques mean lymph node metastases often go undetected preoperatively.
Two patients involved in clinical trials of Tysabri, have contracted a rare and fatal disease, Elan's multiple sclerosis (MS); one has already died. Withdrawal of the drug, eliminates all hope that it will be allowed back on the market this year, or ever.
Vitrolife has received approval from the U.S. Food and Drug Administration, FDA, the equivalent of the Swedish Medical Products Agency, for the products RapitVit™ Blast and RapidWarm™ Blast. So-called 510(k) clearance has been obtained for these products, which are used for so-called vitrification, the rapid freezing and thawing of blastocysts (embryos days 5-7 after fertilization). Vitrolife has since before approved products for vitrification of embryos in an earlier stage of the fertilization (embryos day 2-3 after fertilization).
› Verified 6 days ago
Dr. Aparajita K Mahata, MD F.A.C.O.G. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 110 Hospital Rd, Suite 203, Prince Frederick, MD 20678 Phone: 410-414-4740 Fax: 410-414-4741 | |
Hilary W Ginter, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 110 Hospital Rd Ste 203, Prince Frederick, MD 20678 Phone: 410-414-4740 Fax: 410-414-4741 | |
Dr. Michael W Strider, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 110 Hospital Rd, Suite #202, Prince Frederick, MD 20678 Phone: 410-257-3150 Fax: 410-535-3912 | |
Dr. Diana Soffer, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 301 Steeple Chase Dr Ste 403, Prince Frederick, MD 20678 Phone: 443-530-9424 Fax: 443-338-8238 | |
Dr. Michelle D Johnson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 110 Hospital Rd Ste 203, Prince Frederick, MD 20678 Phone: 410-414-4740 Fax: 410-414-4741 | |
Dr. Barbara K Estes, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 110 Hospital Rd Ste 203, Prince Frederick, MD 20678 Phone: 410-414-4740 Fax: 410-414-4741 |